Sam Altman, the recently ousted CEO of OpenAI, is reportedly engaged in discussions about a potential return to the company that brought the ChatGPT bot to life. Simultaneously, Altman is contemplating the launch of a new artificial intelligence (AI) venture, according to a source with knowledge of the matter.
The unexpected decision to remove Altman from his position as CEO left the tech world in suspense, and now, just a day after his ousting, Altman is actively engaging with OpenAI executives to explore avenues for improving the company’s governance structure. At the same time, he is in talks with key OpenAI researchers and individuals loyal to him, exploring the possibility of establishing a new AI company, reported Reuters.
The fate of Altman, a prominent figure in the realm of generative AI, remains uncertain, with the source cautioning that discussions about a potential return or a fresh start are still in flux. The individual providing this information chose to remain anonymous, citing a lack of authorization to speak on behalf of the involved parties.
Read more: OpenAI’s Altman Calls For Global AI Coordination
Reuters reports investors in OpenAI, including major supporter Microsoft, are in discussions regarding damage control. Concerns about a potential mass exodus of talent without Altman at the helm have prompted discussions about pushing the board to reinstate him as CEO.
Notably, Khosla Ventures, an early supporter of OpenAI, is advocating for Altman’s return to the company. Vinod Khosla, the founder of Khosla Ventures, expressed support for Altman, stating that the fund would back him in his future endeavors.
The sudden management upheaval has triggered heightened emotions among current and former OpenAI employees. Many are expressing anger over Altman’s dismissal and voicing concerns about the potential impact on an upcoming $86 billion share sale. As the situation continues to unfold, the tech community eagerly awaits further developments in the saga surrounding Sam Altman and the future of OpenAI.
Source: Reuters
Featured News
Prime Therapeutics Found in Violation of Antitrust Laws, Arbitrator Rules
Jan 23, 2025 by
CPI
Honda and Nissan Face Challenges in China Amid Potential Merger
Jan 23, 2025 by
CPI
Trump Criticizes EU’s Tech Crackdown, Calls It ‘A Form of Taxation’
Jan 23, 2025 by
CPI
Meta Faces Fresh Allegations of EU Law Breaches in Subscription Service Rollout
Jan 23, 2025 by
CPI
European Commission Investigates Crypto Rules for Cross-Border Stablecoins
Jan 23, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – International Criminal Enforcement
Jan 23, 2025 by
CPI
The Antitrust Division’s Recent Work to Combat International Cartels
Jan 23, 2025 by
Emma Burnham & Benjamin Christenson
Information Sharing: The New Frontier of U.S. Antitrust Enforcement
Jan 23, 2025 by
Brian P. Quinn, Casey Kovarik & Michael Tubach
The Key Role of Guidelines on Exchanges of Information Among Competitors and the Divergent Transatlantic Paths
Jan 23, 2025 by
Rosa Abrantes-Metz & Albert Metz
Leniency, Whistleblowers, and Compliance
Jan 23, 2025 by
Richard Powers, Tara O’Malley & Cory Gordon